All CIRS research papers

7,510 papers, newest first · page 72 of 126

  1. Quantitative glutamate spectroscopic imaging of the human hippocampus

    NMR in Biomedicine · 2006

  2. Metabolite changes in early relapsing–remitting multiple sclerosis

    Journal of Neurology · 2006

  3. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis

    Psychiatry Research Neuroimaging · 2006

  4. Hippocampal glutamate concentration predicts cerebral theta oscillations during cognitive processing

    Psychopharmacology · 2006

  5. Cerebral metabolism in brains of rats infected with neuropathogenic murine leukemia viruses

    Journal of Veterinary Medical Science · 2006

  6. Increased thalamus levels of glutamate and glutamine (Glx) in patients with idiopathic generalised epilepsy

    Journal of Neurology Neurosurgery & Psychiatry · 2006

  7. Cerebral metabolism of glucose and pyruvate in soman poisoning A (13)C nuclear magnetic resonance spectroscopic study. Neurotoxicology 2006. [Epub ahead of print]

    2006

  8. Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas

    Neuroradiology · 2006

  9. Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: A proton magnetic resonance spectroscopy study of the anterior cingulate cortex

    Journal of Affective Disorders · 2006

  10. Single voxel proton magnetic resonance spectroscopy in post-stroke depression. Psychiatry Res 2006. [Epub ahead of print]

    2006

  11. Intrathecal immunoglobulin G synthesis and brain injury by quantitative MRI in multiple sclerosis

    NeuroImmunoModulation · 2006

  12. Oligoclonal bands in multiple sclerosis cerebrospinal fluid: an update on methodology and clinical usefulness

    Journal of Neuroimmunology · 2006

  13. The IL-23/IL-17 axis in inflammation

    J Clin Invest · 2006

  14. Secondary progressive in contrast to relapsing‐remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T‐cell function and FOXP3 expression

    Journal of Neuroscience Research · 2006

  15. Leptin as a proinflammatory cytokine

    Contributions to nephrology · 2006

  16. Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions

    Journal of Surgical Research · 2006

  17. Central neurotranspeptide, alpha-melanocyte-stimulating hormone (alpha-MSH) is upregulated in patients with congestive heart failure

    Internal Medicine · 2006

  18. Role of the melanocortin system in inflammation

    Annals of the New York Academy of Sciences · 2006

  19. α-MSH and γ-MSH modulate early release of hypothalamic PGE2 and NO induced by IL-1β differently

    Neuroscience Letters · 2006

  20. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus

    Neuroscience · 2006

  21. Synthesis and conformational analysis of His-Phe-Arg-Trp-NH2 and analogues with antifungal properties

    Bioorganic & Medicinal Chemistry · 2006

  22. Change in gene expression profile induced by alpha- melanocyte stimulating hormone in a malignant mesothelioma cell line

    Cellular and Molecular Biology · 2006

  23. Non-pigmentary actions of alpha-melanocyte- stimulating hormone-lessons from the cutaneous melanocortin system

    Cellular and Molecular Biology · 2006

  24. Alpha-MSH regulates protein ubiquitination in T cells

    Cellular and Molecular Biology · 2006

  25. Analysis of the transcriptional regulation of melanocytic genes by alpha MSH using the cDNA microarray technique

    Cell Mol Biol (Noisy-le-grand) · 2006

  26. Sabatier N. alpha-Melanocyte-stimulating hormone and oxytocin: a peptide signaling cascade in the hypothalamus

    J Neuroendocrinol · 2006

  27. Effects of α‐Melanocyte‐Stimulating Hormone on Magnocellular Oxytocin Neurones and their Activation at Intromission in Male Rats

    Journal of Neuroendocrinology · 2006

  28. Electroporative α-MSH gene transfer attenuates thioacetamide-induced murine hepatic fibrosis by MMP and TIMP modulation

    Gene Therapy · 2006

  29. Electroporative interleukin-10 gene transfer ameliorates carbon tetrachloride-induced murine liver fibrosis by MMP and TIMP modulation1

    Acta Pharmacologica Sinica · 2006

  30. Relationship between transforming growth factor β1 and anti-fibrotic effect of interleukin-10

    World Journal of Gastroenterology · 2006

  31. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer

    American Journal of Reproductive Immunology · 2006

  32. Targeting melanocortin receptors as potential novel therapeutics

    Pharmacology & Therapeutics · 2006

  33. α‐melanocyte‐stimulating hormone down‐regulates CXC receptors through activation of neutrophil elastase

    European Journal of Immunology · 2006

  34. Schultzberg M. alpha-Melanocyte-stimulating hormone is neuroprotective in rat global cerebral ischemia

    Neuropeptides · 2006

  35. Melanocortin modulation of inflammatory cytokine and neuroendocrine responses to endotoxin in the monkey

    Endocrinology · 2006

  36. The dawn and evolution of hormones in the adenohypophysis

    General and Comparative Endocrinology · 2006

  37. Interactions between gut peptides and the central melanocortin system in the regulation of energy homeostasis

    Peptides · 2006

  38. Circumventing central leptin resistance: lessons from central leptin and POMC gene delivery

    Peptides · 2006

  39. Effect of berberrubine on interleukin-8 and monocyte chemotactic protein-1 expression in human retinal pigment epithelial cell line

    Life Sciences · 2006

  40. Exposure of eyes to perfume: a double-blind, placebo-controlled experiment

    Indoor Air · 2006

  41. The capsaicin cough reflex in eczema patients with respiratory symptoms elicited by perfume

    Contact Dermatitis · 2006

  42. Occupational asthma due to piperazine citrate

    Journal of investigational allergology & clinical immunology · 2006

  43. The clinical significance of electrophysiological measures of olfactory function

    Behavioural Brain Research · 2006

  44. Chemosensory event-related potentials in relation to side of stimulation, age, sex, and stimulus concentration

    Clinical Neurophysiology · 2006

  45. Musical hallucinations

    Current Psychiatry Reports · 2006

  46. Structural and functional neural correlates of music perception

    The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · 2006

  47. Mycobacterium immunogenumCauses Hypersensitivity Pneumonitis-Like Pathology in Mice

    Inhalation Toxicology · 2006

  48. Occurrence of ochratoxin A in wine and ochratoxigenic mycoflora in grapes and dried vine fruits in South America

    International Journal of Food Microbiology · 2006

  49. Ecophysiology of ochratoxigenic Aspergillus ochraceus and Penicillium verrucosum isolates. Predictive models for fungal spoilage prevention – a review

    Food Additives & Contaminants · 2006

  50. Microbiologicals for deactivating mycotoxins

    Molecular Nutrition & Food Research · 2006

  51. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics

    Progress in brain research · 2006

  52. Targeting fibrosis in systemic sclerosis

    Endocrine Metabolic & Immune Disorders - Drug Targets · 2006

  53. A prospective questionnaire assessment of attitudes and experiences of off label prescribing among hospital based paediatricians

    Archives of Disease in Childhood · 2006

  54. The major role of clinicians in the discovery of off-label drug therapies

    SSRN Electronic Journal · 2006

  55. Supply problems of unlicensed and off-label medicines after discharge

    Archives of Disease in Childhood · 2006

  56. Off-Label Use of Antidepressant, Anticonvulsant, and Antipsychotic Medications Among Georgia Medicaid Enrollees in 2001

    The Journal of Clinical Psychiatry · 2006

  57. Off‐label use of medicines: consensus recommendations for evaluating appropriateness

    The Medical Journal of Australia · 2006

  58. United States Medical Practice Summary

    American Journal of Medical Quality · 2006

  59. Designing a strategy to promote safe, innovative off-label use of medications

    American Journal of Medical Quality · 2006

  60. Re: Feasibility of the Use of Phosphodiesterase Type 5 Inhibitors in a Pharmacologic Prevention Program for Recurrent Priapism

    European Urology · 2006